Increased cystatin C serum concentrations in patients with hepatic diseases of various severities.
D000410:Alanine Transaminase / Q000097:blood; D001219:Aspartate Aminotransferases / Q000097:blood; D015415:Biomarkers; D002138:Calibration; D002908:Chronic Disease; D055316:Cystatin C; D015891:Cystatins / Q000097:blood*; D018450:Disease Progression; D006801:Humans; D008107:Liver Diseases / Q000097:blood* / Q000175:diagnosis / Q000503:physiopathology; D008111:Liver Function Tests; D020782:Matrix Metalloproteinases / Q000097:blood; D008991:Monitoring, Physiologic; D011933:Reagent Kits, Diagnostic; D015203:Reproducibility of Results; D019714:Tissue Inhibitor of Metalloproteinases / Q000097:blood; D000509:alpha-Fetoproteins / Q000032:analysis
D015415:Biomarkers; C525030:CST3 protein, human; D055316:Cystatin C; D015891:Cystatins; D011933:Reagent Kits, Diagnostic; D019714:Tissue Inhibitor of Metalloproteinases; D000509:alpha-Fetoproteins; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D020782:Matrix Metalloproteinases